| Literature DB >> 30799969 |
Michael Sc Conlon1,2,3,4, Joseph M Caswell1,2, Stacey A Santi1, Barbara Ballantyne5,6,7, Margaret L Meigs1, Andrew Knight4,5,6,7,8, Craig C Earle9, Mark Hartman6,8.
Abstract
BACKGROUND: Access to palliative care has been associated with improving quality of life and reducing the use of potentially aggressive end-of-life care. However, many challenges and barriers exist in providing palliative care to residents in northern and rural settings in Ontario, Canada. AIM: The purpose of this study was to examine access to palliative care and associations with the use of end-of-life care in a decedent cohort of northern and southern, rural and urban, residents.Entities:
Keywords: Palliative care; health services research; rural health; terminal care
Year: 2019 PMID: 30799969 PMCID: PMC6378418 DOI: 10.1177/1179554919829500
Source DB: PubMed Journal: Clin Med Insights Oncol ISSN: 1179-5549
Figure 1.Map of Ontario Local Health Integration Networks (LHINs). The 2 Northern LHINs depicted in the map are 13-North East and 14-North West. All else constitutes southern Ontario LHINs.
Map from Statistics Canada, 2015 (https://www150.statcan.gc.ca/n1/pub/82-003-x/2015003/article/14144/c-g/fig1-eng.htm).
Associations of receipt of palliative care with demographic and clinical characteristics of Ontario residents who died from cancer (2007-2012).
| Age group | Overall (n°=°129 107) | No palliative care (n°=°33 422) | Palliative care (n°=°95 685) | Crude OR (95% CI) | Adjusted OR (95% CI) |
|---|---|---|---|---|---|
| N (%) | N (%) | N (%) | |||
| 0-34 | 1143 (0.88) | 190 (0.57) | 953 (1.00) | 2.19 (1.87-2.56) | 2.16 (1.85-2.53) |
| 35-44 | 2487 (1.93) | 456 (1.36) | 2031 (2.12) | 1.94 (1.75-2.15) | 1.84 (1.66-2.04) |
| 45-54 | 10 609 (8.22) | 2087 (6.24) | 8522 (8.91) | 1.78 (1.69-1.87) | 1.64 (1.55-1.72) |
| 55-64 | 23 052 (17.85) | 4961 (14.84) | 18 091 (18.91) | 1.59 (1.53-1.65) | 1.47 (1.42-1.52) |
| 65-74 | 33 179 (25.70) | 7928 (23.72) | 25 251 (26.39) | 1.39 (1.35-1.43) | 1.29 (1.25-1.34) |
| 75+ | 58 637 (45.42) | 17 800 (53.26) | 40 837 (42.68) |
|
|
| Sex | |||||
| Female | 60 732 (47.04) | 14 868 (44.49) | 45 864 (47.93) |
|
|
| Male | 68 375 (52.96) | 18 554 (55.51) | 49 821 (52.07) | 0.87 (0.85-0.89) | 0.83 (0.81-0.85) |
|
|
| ||||
| Charlson index | 4.37 (2.87) | 5.26 (2.65) | 1.13 (1.12-1.13) | 1.12 (1.11-1.12) | |
| Duration of disease | 3.83 (4.61) | 3.25 (4.06) | 0.97 (0.97-0.97) | 0.98 (0.98-0.98) | |
| Cancer type | |||||
| Hematologic | 4634 (3.59) | 1545 (4.62) | 3089 (3.23) | 0.67 (0.62-0.71) | 0.86 (0.80-0.92) |
| Prostate | 7499 (5.81) | 2151 (6.44) | 5348 (5.59) | 0.83 (0.78-0.87) | 1.08 (1.02-1.15) |
| Breast | 9804 (7.59) | 2639 (7.90) | 7165 (7.49) | 0.90 (0.86-0.95) | 0.82 (0.78-0.87) |
| Colorectal | 14 452 (11.19) | 3701 (11.07) | 10 751 (11.24) | 0.97 (0.92-1.01) | 0.98 (0.94-1.03) |
| Lung | 31 381 (24.31) | 7830 (23.43) | 23 551 (24.61) |
|
|
| Other | 61 337 (47.51) | 15 556 (46.54) | 45 781 (47.85) | 0.98 (0.95-1.01) | 1.02 (0.99-1.05) |
| Income quintile[ | |||||
| 1 | 27 034 (21.02) | 7191 (21.61) | 19 843 (20.81) | 0.95 (0.91-0.99) | 0.91 (0.87-0.94) |
| 2 | 27 171 (21.12) | 7014 (21.08) | 20 157 (21.14) | 0.99 (0.95-1.03) | 0.96 (0.92-1.00) |
| 3 | 25 015 (19.45) | 6447 (19.38) | 18 568 (19.47) | 0.99 (0.95-1.03) | 0.97 (0.93-1.01) |
| 4 | 25 093 (19.51) | 6402 (19.24) | 18 691 (19.60) | 1.00 (0.95-1.03) | 0.98 (0.94-1.02) |
| 5 | 24 325 (18.91) | 6219 (18.69) | 18 106 (18.99) |
|
|
| Location | |||||
| North/rural | 3737 (2.89) | 1120 (3.35) | 2617 (2.74) | 0.82 (0.76-0.88) | 0.82 (0.76-0.88) |
| North/urban | 6835 (5.29) | 1640 (4.91) | 5195 (5.43) | 1.11 (1.05-1.17) | 1.11 (1.04-1.17) |
| South/rural | 15 086 (11.68) | 3882 (11.62) | 11 204 (11.71) | 1.01 (0.97-1.05) | 1.03 (0.99-1.07) |
| South/urban | 103 449 (80.13) | 26 780 (80.13) | 76 669 (80.13) |
|
|
| Index year | |||||
| 2007 | 20 417 (15.81) | 6010 (17.98) | 14 407 (15.06) |
|
|
| 2008 | 20 927 (16.21) | 5587 (16.72) | 15 340 (16.03) | 1.15 (1.10-1.20) | 1.16 (1.11-1.21) |
| 2009 | 21 113 (16.35) | 5364 (16.05) | 15 749 (16.46) | 1.23 (1.17-1.28) | 1.26 (1.20-1.31) |
| 2010 | 21 747 (16.84) | 5006 (14.98) | 16 741 (17.50) | 1.40 (1.34-1.46) | 1.45 (1.39-1.52) |
| 2011 | 22 304 (17.28) | 5468 (16.36) | 16 836 (17.60) | 1.28 (1.23-1.34) | 1.34 (1.29-1.40) |
| 2012 | 22 599 (17.50) | 5987 (17.91) | 16 612 (17.36) | 1.16 (1.11-1.21) | 1.20 (1.15-1.26) |
Abbreviation: CI, confidence interval.
Odds ratios (OR) reflect receipt of palliative care.
Missing: nº=º469.
Associations of receipt of potentially aggressive end-of-life care or death in acute care hospital.
| Overall (n°=°129 107) | Palliative care (n°=°95 685) | No palliative care (n°=°33 422) | Crude OR (95% CI) | Adjusted OR (95% CI)[ | |
|---|---|---|---|---|---|
| N (%) | N (%) | N (%) | |||
|
| |||||
| None received | 96 787 (74.97) | 74 987 | 21 800 |
|
|
| Received aggressive care | 32 320 (25.03) | 20 698 | 11 622 | 1.93 (1.88-1.99) | 2.30 (2.24-2.37) |
| None received | 124 612 (96.52) | 92 836 (97.02) | 31 776 (95.08) |
|
|
| Received chemotherapy | 4495 (3.48) | 2849 (2.98) | 1646 (4.92) | 1.69 (1.59-1.80) | 1.90 (1.78-2.03) |
| No admission | 119 786 (92.78) | 90 860 (94.96) | 28 926 (86.55) |
|
|
| ICU admission | 9321 (7.22) | 4825 (5.04) | 4496 (13.45) | 2.93 (2.80-3.05) | 3.42 (3.27-3.58) |
| No hospitalizations | 118 020 (91.41) | 88 180 (92.16) | 29 840 (89.28) |
|
|
| Hospitalization | 11 087 (8.59) | 7505 (7.84) | 3582 (10.72) | 1.41 (1.35-1.47) | 1.71 (1.64-1.78) |
| No ED visits | 110 244 (85.39) | 82 978 (86.72) | 27 266 (81.58) |
|
|
| ED visits | 18 863 (14.61) | 12 707 (13.28) | 6156 (18.42) | 1.47 (1.43-1.53) | 1.66 (1.60-1.72) |
|
| |||||
| No death in an acute care hospital | 68 141 (52.79) | 53 316 (55.72) | 14 825 (44.36) |
|
|
| Died in an acute care hospital | 60 966 (47.22) | 42 369 (44.28) | 18 597 (55.64) | 1.58 (1.54-1.62) | 2.01 (1.96-2.07) |
Abbreviations: CI, confidence interval; ED, emergency department; ICU, intensive care unit.
Odds ratios (OR) reflect lack of palliative care.
Adjusted for all variables in Table 1.
Figure 2.Indicators of aggressive end-of-life care in northern and rural Ontario cancer patients with (solid line) or without (dashed line) a palliative designation between 2007 and 2012: (A) delivery of chemotherapy in the last 14 days, (B) admission to an intensive care unit in the last 30 days of life, (C) more than one hospitalization in the last 30 days of life, and (D) more than one visit to the emergency department (ED) in the last 30 days of life.
Figure 3.Aggressive end-of-life care and death in acute care between rural and urban residences within northern or southern Ontario from 2007 to 2012: (A) percentage of cancer patients who received any aggressive end-of-life care who had a northern or southern rural or urban residence. (B) Percentage of cancer patients who died in an acute care setting who had a rural or urban residence.
Figure 4.Indicators of aggressive end-of-life care between rural and urban residences located within either northern or southern Ontario. Percentage of cancer patients with a rural or urban residence in northern or southern Ontario who (A) received chemotherapy within the last 14 days of life, (B) were admitted to an intensive care unit within the last 30 days of life, (C) had more than one hospitalization in the last 30 days of life, and (D) had more than one emergency department visit in the last 30 days of life.